The Metzger Law Group supports the Leukemia & Lymphoma Society and the International Myeloma Foundation

 

New Swedish Study Shows Acrylamide Likely Causes Esophageal Cancer

 

Researchers from the Karolinska Institute in Stockholm, Sweden have published a population-based case-control study linking esophageal cancer to dietary acrylamide intake. They collected data on diet among 189 cases of esophageal adenocarcinoma, 262 cases of gastroesophageal junctional adenocarcinoma, 167 cases of esophageal squamous cell carcinoma, and 820 controls.  Dietary intake of acrylamide exposure was assessed from a food-frequency questionnaire and categorized into quartiles based on the consumption among the control participants.  Unconditional logistic regression was used to calculate odds ratios (OR) with 95% confidence intervals (CI), with multivariable adjustment for known risk factors.  Among participants in the highest quartile of acrylamide exposure compared to the lowest, the adjusted risk of all esophageal tumors combined was significantly increased (OR 1.23, 95% CI 1.02-1.75), particularly among overweight or obese persons (OR 1.88, 95% CI 1.06-3.34).  Increased point risk estimates were found for each type of esophageal cancer, but the association with esophageal squamous cell carcinoma seemed stronger and was statistically significant, particularly among non-smokers in the highest quartile of acrylamide exposure (adjusted OR 2.82, 95% CI 1.16-6.87).  Regarding squamous cell carcinoma only, a dose-response association was identified (p for trend 0.01).  Based on these data, the investigators concluded that dietary intake of acrylamide increases the risk of developing esophageal cancer.

 

 

Lin, Y., et al., “Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden.” Int. J. Cancer. 2010 Aug 16; [Epub ahead of print]



Practice Concentrated